The Right TraderBeta

Spyre Therapeutics, Inc.

SYRE
—
Advanced chart & tools →
Spyre Therapeutics, Inc.SYRE
$0.00
+$0.00(+NaN%)Past Year
$0.00$0.00$0.00$0.00
Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap
—
P/E ratio
—
EPS (diluted)
$-49.12
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$0
Net income
$-155.20M
Net margin
—
Gross margin
—

Dividends & financials

Spyre Therapeutics, Inc. (SYRE) reported revenue of $0 and net income of $-155.20M, or $-49.12 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.